middle.news
Mesoblast Prepares to Unveil Half-Year Results Amid Global Expansion
6:02pm on Friday 20th of February, 2026 AEDT
•
Healthcare
Read Story
Mesoblast Prepares to Unveil Half-Year Results Amid Global Expansion
6:02pm on Friday 20th of February, 2026 AEDT
Key Points
Upcoming webcast for H1 2026 financial and operational results
FDA-approved Ryoncil therapy for pediatric inflammatory disease
Development pipeline includes treatments for heart failure and chronic pain
Strong global intellectual property portfolio extending to 2044
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MESOBLAST (ASX:MSB)
OPEN ARTICLE